Clinical trial
Clinical Trial in Patients With Metastatic Colorectal Cancer
NCT00235898 · Mast Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00235898 |
|---|---|
| Title | Clinical Trial in Patients With Metastatic Colorectal Cancer |
| Official title | A Multi-Center, Open Label, Parallel Group, Randomised, Phase IIB Clinical Trial to Evaluate the Safety and Efficacy of CoFactor and 5-FU Versus Leucovorin and 5-FU in Subjects With Metastatic Colorectal Carcinoma |
| Lead sponsor | Mast Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colon Cancer, Rectal Cancer |
| Intervention type | Drug |
| Interventions | CoFactor, 5-FU, Leucovorin |
| Enrollment | 300 |
| Start date | May 1, 2005 |
| Primary completion | Mar 1, 2008 |
| First posted | Oct 12, 2005 |
| Last update posted | Aug 25, 2008 |
| Countries | India, Poland, Romania, Serbia, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: